Surmodics reported $19.71M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6324M 584M
Align Technology ALGN:US $ 687.56M 21.79M
Anika Therapeutics ANIK:US $ 24.86M 3.06M
Baxter International BAX:US $ 1457M 107M
Bioscrip BIOS:US $ 216.9M 15.96M
Boston Scientific BSX:US $ 2222M 163M
Cryolife CRY:US $ 52.17M 1.45M
Edap Tms EDAP:US $ 6.5M 0.13M
Edwards Lifesciences EW:US $ 1104.5M 62.6M
Haemonetics HAE:US $ 142.06M 5.79M
Johnson & Johnson JNJ:US $ 16101M 273M
Merit Medical Systems MMSI:US $ 135.07M 14.16M
Mesa Laboratories MLAB:US $ 31.34M 3.77M
Nektar Therapeutics NKTR:US $ 16.47M 3.04M
Stryker SYK:US $ 2843M 116M
Surmodics SRDX:US $ 19.71M 1.29M
Trinity Biotech TRIB:US $ 7.27M 0.03M